We are live on ! Find out more
FIM

Fernwood Investment Management Portfolio holdings

AUM $288M
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$187M
AUM Growth
+$27.3M
Cap. Flow
+$18.8M
Cap. Flow %
10.04%
Top 10 Hldgs %
34.89%
Holding
157
New
19
Increased
35
Reduced
66
Closed
8

Sector Composition

Rank Sector Weight
1 Healthcare 28.74%
2 Energy 8.15%
3 Consumer Staples 6.41%
4 Technology 6.23%
5 Financials 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GBT
1
DELISTED
Global Blood Therapeutics, Inc.
GBT
$14.1M 7.56%
359,094
-58,916
-14% -$2.2M
MYOK
2
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$11.1M 5.95%
264,454
+18,072
+7% +$696K
PTLA
3
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$11.1M 5.95%
228,577
-1,000
-0.4% -$50.6K
IVV icon
4
iShares Core S&P 500 ETF
IVV
$858B
$5.83M 3.12%
+21,670
New +$5.68M
MO icon
5
Altria Group
MO
$125B
$5M 2.67%
69,944
+700
+1% +$46.9K
META icon
6
Meta Platforms (Facebook)
META
$1.49T
$4.27M 2.29%
24,213
-270
-1% -$47.7K
IYK icon
7
iShares US Consumer Staples ETF
IYK
$1.44B
$3.75M 2.01%
88,770
-906
-1% -$37.2K
GILD icon
8
Gilead Sciences
GILD
$165B
$3.53M 1.89%
49,243
-2,790
-5% -$212K
CVS icon
9
CVS Health
CVS
$135B
$3.4M 1.82%
46,873
-1,600
-3% -$116K
BIIB icon
10
Biogen
BIIB
$30.9B
$3.08M 1.65%
9,675
-225
-2% -$72.2K
DVY icon
11
iShares Select Dividend ETF
DVY
$23.8B
$3.05M 1.63%
30,960
+22,216
+254% +$2.14M
PM icon
12
Philip Morris
PM
$309B
$2.97M 1.59%
28,083
+1,041
+4% +$111K
IWM icon
13
iShares Russell 2000 ETF
IWM
$79.1B
$2.94M 1.57%
+19,291
New +$2.9M
IRM icon
14
Iron Mountain
IRM
$35.9B
$2.74M 1.47%
72,708
-2,054
-3% -$81.5K
JNJ icon
15
Johnson & Johnson
JNJ
$640B
$2.74M 1.47%
19,623
-200
-1% -$27.9K
V icon
16
Visa
V
$677B
$2.65M 1.42%
23,262
+295
+1% +$32.6K
IJH icon
17
iShares Core S&P Mid-Cap ETF
IJH
$121B
$2.59M 1.38%
+68,175
New +$2.52M
IWB icon
18
iShares Russell 1000 ETF
IWB
$47.1B
$2.46M 1.31%
+16,529
New +$2.39M
AAPL icon
19
Apple
AAPL
$4.97T
$2.44M 1.3%
57,572
+6,480
+13% +$271K
UNP icon
20
Union Pacific
UNP
$174B
$2.42M 1.3%
18,060
-600
-3% -$72.4K
GLNG icon
21
Golar LNG
GLNG
$4.82B
$2.39M 1.28%
80,250
-600
-0.7% -$14.4K
MGK icon
22
Vanguard Morningstar Mega Cap Growth ETF
MGK
$31.3B
$2.08M 1.11%
93,600
+645
+0.7% +$14K
PSX icon
23
Phillips 66
PSX
$82.9B
$2.03M 1.08%
20,051
-407
-2% -$38.7K
XOM icon
24
ExxonMobil
XOM
$650B
$2.02M 1.08%
24,090
-145
-0.6% -$12K
WY icon
25
Weyerhaeuser
WY
$17.6B
$2.01M 1.07%
56,970
-2,050
-3% -$72.5K

Similar funds

Fernwood Investment Management's Q4 2017 Portfolio in Review

As of Q4 2017, Fernwood Investment Management held 157 positions worth $187M, up 17% from $160M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Fernwood Investment Management deployed $18.8M of net new capital in Q4 2017, opening 19 new positions and adding to 35 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 21,670 shares worth $5.83M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 33% a quarter earlier, followed by Energy and Consumer Staples.

On the sell side, the largest reduction was Global Blood Therapeutics, Inc., an estimated $2.2M trimmed.

  • Fernwood Investment Management's largest Q4 2017 buy was iShares Core S&P 500 ETF: 21,670 shares worth $5.83M.
  • Fernwood Investment Management added most to iShares Select Dividend ETF in Q4 2017, an estimated $2.14M increase.
  • Fernwood Investment Management's biggest Q4 2017 reduction was Global Blood Therapeutics, Inc., cutting an estimated $2.2M.
  • Fernwood Investment Management fully exited Teva Pharmaceuticals in Q4 2017, selling an estimated $319K.
  • Fernwood Investment Management's ten largest holdings make up 35% of its $187M portfolio in Q4 2017.
  • Fernwood Investment Management opened 19 new positions and closed 8 in Q4 2017.
  • Fernwood Investment Management's portfolio value rose 17% quarter-over-quarter to $187M.

Based on Fernwood Investment Management's 13F filing for Q4 2017, filed 5 Feb 2018.